COMPANY
Theragenics
FDA-cleared device company Past trials only
Timeline
- Trial start Phase 1/Phase 2: Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT00100087 | Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System | Phase 1/Phase 2 | Unknown status (ClinicalTrials.gov) | 2004-10 | Not listed |